Heart Disease News and Research

Latest Heart Disease News and Research

Annexin A5 protein may have therapeutic potential for treatment of sepsis

Sepsis is the leading cause of in-hospital death and there is no specific treatment for it. Now, research led by Dr. Qingping Feng of Western University (London, Canada) suggests a protein called recombinant human annexin A5 may have therapeutic potential for the treatment of this disease. The paper is published in advance, online in Critical Care Medicine.

15 Nov 2013

Kaiser Permanente to open doors to brand new specialty center in Lone Tree, Colorado

After years of planning, construction and preparation, Kaiser Permanente will open the doors to a brand new specialty center in Lone Tree on December 2nd. This is the largest construction project and the most significant addition to the health plan's brick-and-mortar presence in Colorado in nearly a decade.

15 Nov 2013

Global Genomics Group, Metabolon partner to discover novel targets for cardiovascular diseases

Global Genomics Group and Metabolon today announced that they have entered into a collaboration agreement to investigate biological networks and pathways in order to discover novel biomarkers and pharmaceutical targets for cardiovascular diseases.

15 Nov 2013

Men’s cognitive advantage maintained in early bipolar disorder

Patients in the early stages of bipolar disorder show the same gender differences in cognitive functioning as mentally healthy individuals, findings from the STOP-EM trial show.

14 Nov 2013

Svelte completes enrollment in drug-eluting coronary stent Integrated Delivery System study

Svelte Medical Systems today announced enrollment of the final patient in the DIRECT II (Direct Implantation of Rapamycin-Eluting stents with bioabsorbable drug Carrier Technology) clinical study. DIRECT II is a prospective, randomized study comparing the safety and efficacy of the Svelte drug-eluting coronary stent Integrated Delivery System (IDS) to the Medtronic Resolute Integrity drug-eluting stent in 159 patients at 19 investigative sites.

From Medtronic 14 Nov 2013

Severe sepsis mortality rates decrease over the past 20 years

A recent study from Boston University School of Medicine and Boston Medical Center shows a significant decrease in severe sepsis mortality rates over the past 20 years. Looking at data from patients with severe sepsis enrolled in clinical trials, researchers found that in-hospital mortality rates decreased from 47 percent between 1991 and 1995 to 29 percent between 2006 and 2009, a time period when no new pharmacological treatments were developed for severe sepsis.

14 Nov 2013

New procedure repairs the mitral valve in patients at high risk for open heart surgery

A minimally invasive procedure is the first effective treatment for patients who are high risk for standard open heart surgery for a leaking heart valve, a study led by a University of Virginia School of Medicine researcher has found.

14 Nov 2013

Artificial trans fatty acids not needed anymore

Artificial trans fatty acids are no longer needed in advanced technological societies, says metabolic disease expert Henry Pownall, Ph.D., a chemist who has been studying fatty acid and cholesterol metabolism for over four decades.

14 Nov 2013

New research devises effective way to evaluate severity of pulmonary hypertension

An aim to improve the outlook for people suffering from pulmonary hypertension is the focus of research at Griffith University.

14 Nov 2013

Cardiologists question FDA recommendations on genetic testing before taking Plavix

Which antiplatelet medication is best after a coronary stent? The costly and potential life-or-death question lingers after most of the 600,000 angioplasties performed every year in the United States. The answer may lie in your genes, but professional cardiovascular societies and many working cardiologists question the U.S. Food and Drug Administration's recent recommendation that patients undergo genetic testing before taking Plavix (clopidogrel bisulfate).

14 Nov 2013

TAILORED-Treatment project to increase effectiveness of antibiotics receives EU funding

The European Union has funded a 4 year project called TAILORED-Treatment with € 6.000.000,-. The main goal of TAILORED -Treatment is to establish a strategy that can be used to increase the effectiveness of antibiotic treatment, reduce any potential side-effects of therapy, and help limit the emergence of antimicrobial resistance in hospitalized children and adults. The project will be coordinated by Erasmus MC, Rotterdam, the Netherlands.

14 Nov 2013

Johns Hopkins students take the top honor for developing PrestoPatch system

A Johns Hopkins undergraduate biomedical engineering student team that devised a two-part system to improve the way life-saving shocks are delivered to hearts earned first-prize in the undergraduate division of a national Collegiate Inventors Competition. In the graduate-level competition, Isaac Kinde, a Johns Hopkins medical student, received third-place honors for developing a test to detect ovarian and endometrial cancers as part of a team at the Johns Hopkins Kimmel Cancer Center.

14 Nov 2013

Skeletal problems now added to list of diabetes complications

The list of complications from type 2 diabetes is long: vascular and heart disease, eye problems, nerve damage, kidney disease, hearing problems and Alzheimer's disease. Physicians have long thought of osteoporosis as another outcome. Based on a Mayo Clinic study published in the Journal of Bone and Mineral Research, that's confirmed: You can definitely add skeletal problems to that list.

14 Nov 2013

Mount Sinai researchers successfully test SUMO-1 gene therapy to reverse heart failure

Researchers at the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai have successfully tested a powerful gene therapy, delivered directly into the heart, to reverse heart failure in large animal models.

14 Nov 2013

Over 50% of nonsurgical patients prescribed opioids during hospitalizations, analysis finds

Amid a growing climate of concern regarding the overuse of opioid pain medications, a comprehensive analysis of more than 1 million hospital admissions has found that over 50 percent of all nonsurgical patients were prescribed opioids during their hospitalizations -- often at very high doses -- and that more than half of those exposed were still receiving these medications on the day they were discharged from the hospital.

14 Nov 2013

New initiative launched to increase access to clean drinking water in Africa

3000 children in Africa die every day from diseases spread through drinking contaminated water. Robin Moore, a donor and partner of The Joseph Assignment Global Initiative, is doing something about it. She has launched the 100 Day Challenge for Clean Water in Africa. She seeks donations from family, friends, and others concerned about the plight of these children to partner with The Joseph Assignment Global Initiative effort to ship two well drilling machines to Ghana, Africa, in order to effectively increase access to clean drinking water needed to save lives.

14 Nov 2013

Groundbreaking study reveals novel approach to treat, eliminate MRSA infection

Recent work from University Distinguished Professor of Biology Kim Lewis promises to overcome one of the leading public health threats of our time. In a groundbreaking study published Wednesday in the journal Nature, Lewis' team presents a novel approach to treat and eliminate methicillin resistant staphylococcus aureus, or MRSA, a potent bacterium whose resistance to antibiotics has kept it one step ahead of researchers.

14 Nov 2013

Novel study explores effects of meditation on the heart and vascular system

Demystifying meditation with science, researchers at the Scripps Translational Science Institute have teamed with The Chopra Foundation and The Chopra Center for Wellbeing in a novel study of the ancient practice that uses wireless health sensors to collect physiological data from meditators.

14 Nov 2013

Bay Area Surgical Management reaches agreement to become in-network provider for Cigna

Bay Area Surgical Management, one of the largest and fastest growing ambulatory surgery center providers in the San Francisco Bay Area, has reached an agreement to become an in-network provider for Cigna, one of the country's largest health insurance companies.

13 Nov 2013

TopPac® 20 ml prefillable polymer syringe for infusion therapy introduced by SCHOTT

SCHOTT expanded its range of TopPac polymer syringes to include a 20 milliliter (ml) format that can be used in combination with syringe pumps for infusion therapy. SCHOTT TopPac® prefillable syringes (PFS) simplify the infusion therapy preparation process and can ultimately reduce costs for pharmaceutical companies and health care facilities.

13 Nov 2013

Heart Disease News and Research

Latest Heart Disease News and Research

Annexin A5 protein may have therapeutic potential for treatment of sepsis

Kaiser Permanente to open doors to brand new specialty center in Lone Tree, Colorado

Global Genomics Group, Metabolon partner to discover novel targets for cardiovascular diseases

Men’s cognitive advantage maintained in early bipolar disorder

Svelte completes enrollment in drug-eluting coronary stent Integrated Delivery System study

Severe sepsis mortality rates decrease over the past 20 years

New procedure repairs the mitral valve in patients at high risk for open heart surgery

Artificial trans fatty acids not needed anymore

New research devises effective way to evaluate severity of pulmonary hypertension

Cardiologists question FDA recommendations on genetic testing before taking Plavix

TAILORED-Treatment project to increase effectiveness of antibiotics receives EU funding

Johns Hopkins students take the top honor for developing PrestoPatch system

Skeletal problems now added to list of diabetes complications

Mount Sinai researchers successfully test SUMO-1 gene therapy to reverse heart failure

Over 50% of nonsurgical patients prescribed opioids during hospitalizations, analysis finds

New initiative launched to increase access to clean drinking water in Africa

Groundbreaking study reveals novel approach to treat, eliminate MRSA infection

Novel study explores effects of meditation on the heart and vascular system

Bay Area Surgical Management reaches agreement to become in-network provider for Cigna

TopPac® 20 ml prefillable polymer syringe for infusion therapy introduced by SCHOTT

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Heart Disease News and Research

Latest Heart Disease News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in